Skip to content
Investing

NANO Nuclear Energy Investor Profile: KRONOS, $580m of Cash and a Long Road to Revenue

NANO Nuclear Energy is licensing its KRONOS microreactor in Illinois and building fuel and transport units. It held about $580m of cash in June, but its first reactor is not due until around 2030.

NANO Nuclear Energy and Hyundai Engineering representatives hold up signed documents at the KRONOS MMR memorandum of understanding signing ceremony on 23 October 2026.
Photo: NANO Nuclear Energy

NANO Nuclear Energy is a New York company developing small nuclear reactors and the fuel and transport businesses around them. It held about $580m of cash and short-term investments at the end of June and has little in the way of liabilities, but its first reactor is not expected to run until around 2030 and its revenue so far is tiny.

What NANO Nuclear does and where

The company's shares trade on Nasdaq as NNE. It is based at Times Square in New York and works through subsidiaries that each cover part of the nuclear chain: KRONOS MMR and LOKI MMR for reactors, HALEU Energy Fuel for fuel, Advanced Fuel Transportation for moving it, plus Nano Nuclear Space, American Uranium and True North Nuclear in Canada.

Its lead product is KRONOS, a stationary high-temperature gas-cooled microreactor that runs on TRISO fuel, in which uranium is sealed inside small coated particles. The first planned unit is at the University of Illinois Urbana-Champaign. LOKI is a portable design aimed at uses including space, and ZEUS is a portable solid-core battery reactor designed for military customers. In March the company agreed to sell the design and intellectual property of a fourth reactor, ODIN, to Cambridge Atomworks. The agreement was amended in June, and the sale was still pending at the company's last quarterly report, with closing expected by 30 November.

The financial year ends on 30 September. The company had 85 employees and contractors at the end of June, up from 31 a year earlier.

NANO Nuclear Energy: share price, chart and news

NANO Nuclear Energy's engineering team in hard hats in front of a large steel vessel component at IMPSA's manufacturing facility, on a project kickoff visit after the two companies agreed to work on KRONOS MMR components.
NANO Nuclear Energy's engineering team in hard hats in front of a large steel vessel component at IMPSA's manufacturing facility, on a project kickoff visit after the two companies agreed to work on KRONOS MMR components. Photo: NANO Nuclear Energy

Where KRONOS stands

The university submitted a construction permit application for KRONOS to the Nuclear Regulatory Commission on 31 March, and the regulator accepted it for review on 18 May. Chief executive James Walker called the acceptance "one of the most important milestones in our development program".

In an update on 13 October, the company said the review was in the NRC's audit phase, which it expects to finish in the coming months. The regulator's public schedule targets a draft environmental assessment and a draft safety evaluation in February 2027, a final environmental assessment in May 2027 and a final safety evaluation in September 2027. NANO Nuclear hopes to begin initial construction work in the second half of 2027, subject to approvals. Its latest quarterly report points to initial operation around 2030 and aims for a commercial launch in the early 2030s, with no assurance that these goals will be met.

The company is also chasing larger uses for KRONOS. It has completed a 1 GW feasibility study for BaRupOn's data centre and manufacturing campus in Texas, signed a memorandum of understanding with Supermicro on pairing KRONOS with AI server platforms, and holds US Air Force AFWERX awards linked to a possible deployment at Joint Base Anacostia-Bolling. On 27 October it signed a memorandum of understanding with Hyundai Engineering on planning the Illinois project and possible later fleet deployment, which commits neither side to funding or construction. None of these is a firm order for a reactor.

Fuel and transport

NANO Nuclear wants to control more of its supply chain. In May it bought Secured Transportation Services, a nuclear logistics firm that reported audited 2025 revenue of about $7.1m and net income of about $1.3m. Its transport arm also holds an exclusive licence to a high-capacity transport basket for HALEU fuel, developed by three US national laboratories.

On fuel, the work is earlier still. NANO Nuclear is the key subcontractor on a US Department of Energy uranium enrichment contract led by LIS Technologies (LIST), a related party that shares common ownership and management with NANO Nuclear. It has also submitted a proposal to Dioxitek in Argentina for a uranium hexafluoride facility, but no definitive agreement has been signed.

On 1 October it announced a deal to buy an NRC-licensed but never-built uranium deconversion project in Lea County, New Mexico, for $9.5m in cash and $4m in shares. The deal needs NRC consent to the licence transfer and a site agreement with the county, and the company has made no decision to build a plant.

The latest numbers

MeasureQ3 FY2026 (to 30 June)Q3 FY2025Nine months FY2026
Revenue$0.21m$0$0.21m
Research and development$4.0m$3.7m$15.1m
General and administrative$11.9m$5.3m$27.3m
Loss from operations$15.8m$9.4m$41.5m
Interest income$5.0m$1.5m$14.8m
Net loss$10.1m$7.6m$25.8m

Interest on the cash pile offsets a large part of the cost of running the business: in the nine months to June, interest income of $14.8m covered more than a third of the $41.5m operating loss. Operations used $18.7m of cash over the same period. The first revenue, $0.21m, came from consulting work.

Balance sheet, 30 June 2026

  • $580m cash, cash equivalents and short-term investments
  • $12.0m total liabilities
  • 53.7m shares outstanding on 10 August

Most of the money came from selling shares. In the nine months to June, NANO Nuclear issued about 9.5m shares for $426.8m before costs, including an October 2025 private placement and sales through its at-the-market programme. Management says working capital is enough for at least the next twelve months, while noting that its future depends on raising more money and eventually earning revenue.

Risks and what to watch

Main risks

  • No reactor revenue yet. KRONOS is still in licensing, and first operation is targeted around 2030.
  • Regulatory timing. NRC reviews of new reactor designs and fuel licences can take longer than planned.
  • Dilution. The share count has grown quickly, and further share sales would add more.
  • Execution. The company is pursuing reactors, fuel, transport and acquisitions at the same time.
  • Third parties. KRONOS depends on the University of Illinois and on fuel and materials supply chains that are still being built.
  • Litigation. One shareholder suit was dismissed at trial but remains open to appeal.
WhenWhat
By 30 November 2026Expected closing of the ODIN design sale
Date not yet setResults for the financial year to 30 September 2026
Late January 2027Deadline for the New Mexico deal conditions, which NANO Nuclear can extend by 60 days
February 2027Draft NRC environmental assessment and draft safety evaluation of KRONOS, on the regulator's public schedule
May 2027Final NRC environmental assessment targeted
September 2027Final NRC safety evaluation targeted
Second half of 2027Targeted start of KRONOS construction
Around 2030Targeted initial operation of KRONOS

Sources

Related stories

Business

NANO Nuclear Energy Agrees to Buy NRC-Licensed New Mexico Fuel Processing Assets for $13.5m

NANO Nuclear Energy has agreed to buy an NRC-licensed but never-built uranium deconversion project in Lea County, New Mexico, for $9.5m in cash and $4m in shares, subject to…

Investing

Uranium Energy Corp: A Debt-Free US Uranium Miner That Sells at Spot Prices

Uranium Energy Corp runs uranium mines in Wyoming and Texas, holds $495m of cash and no debt, and sells at spot prices. What it owns, what it earns, the risks and the dates to…

Investing

Kraig Biocraft Laboratories Profile: Spider Silk From Silkworms, Still Before Revenue

Kraig Biocraft Laboratories breeds silkworms that spin spider silk and farms them in Vietnam. It has begun shipping yarn but reported no revenue in the first half and carries a…

Investing

Atha Energy: Investor Profile of the Uranium Explorer Behind Nunavut's Angilak Project

Atha Energy explores for uranium at Angilak in Nunavut, in Labrador and in the Athabasca Basin. Its assets, latest reported numbers, cash, share count, main risks and the dates to…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…